MARKET WRAP: Indices end flat, Sensex up 60 pts; ITC, TCS rise nearly 2%
All that happened in the markets today
2:07 PM
Sharp rise in IRCTC
2:06 PM
NEWS ALERT :: RBI announces Special OMO for Rs 10,000 cr on Sept 10
2:02 PM
BROKERAGE VIEW:: HDFC Securities on Berger Paints
RATING: SELL | TARGET PRICE: Rs 460
While BRGR remains a credible No. 2 in paints; at 66x Sept-22 P/E (18% premium to APNT), risk-reward seems unfavorable. We assign a DCF-based TP of Rs. 460/sh (implying 55x Sep-21 P/E). Implied assumptions: (1) 10-year revenue CAGR: 12.6%, (2) FY20-30E/FY30-41E FCFF CAGR: 20/13.5% resp. (3) WACC: 10.5%, and (4) terminal growth: 6%, FCF/PAT conversion of ~70% over FY20-30E. Initiate with a Sell Reco.
1:57 PM
MARKET CHECK:: Top 5 losers on the BSE at this hour
1:49 PM
Expert View :: Yash Gupta - Equity Research Associate at Angel Broking on AllCargo delisting's floor price
Allcargo Logistics Ltd board approves delisting proposal and set floor price at ₹92.58, which is 18.8% discount to its current market price of ₹114.15.Promoter and promoter group of the company will acquire all the fully paid-up equity shares of the company having a face value of ₹2 held by the public shareholders of the Company. As per the last filling, the public holds 29.99% of paid-up equity share capital of the company. Delisting will be a positive development for the Company but the proposed delisting prices is not upto expectation of public shareholders
1:41 PM
BUZZING STOCK:: NTPC slips nearly 3%
1:34 PM
NEWS ALERT :: Fitch cuts India FY21 GDP forecast to -10.5% from -5% earlier
1:27 PM
MARKET CHECK:: Most realty stocks slip in trade; S&P BSE Realty index dips 1%
1:12 PM
BUZZING STOCK:: Wabco India leaps 10%, hits new 52-week high
1:03 PM
BROKERAGE VIEW:: Edelweiss Securities on Heritage Foods
Heritage Foods (HFL) has doubled from its March low (down 58% from its January-2018-high). FY20 was a challenging year owing to a harsh season, which dragged down core EBITDA 32% YoY. That said, we remain convinced about HFL’s prospects following: i) Margin revival on the back of benign milk prices and pricing power to drive up EBITDA 30% in FY21 (up 25% YoY in Q1FY21). ii) Robust B2C milk portfolio (65% of sales) relatively insulated from covid-19 fallout. iii) Focus on technology-enabled integrated milk procurement and a consistent scale-up (procurement up 34% in last three years). All in all, we expect RoCE to jump 640bps in FY21 and 860bps over FY20–22 to 23%. Hence, we are revising up TP by ~15% to Rs 456 as we are raising the core business’s PE by 15% to 18x FY22E (15.5x earlier). We however, are raising the discount on its stake in Future Retail from 20% to 30% (in the wake of RIL’s buyout). Maintain ‘BUY’.
1:02 PM
BROKERAGE VIEW:: Centrum Broking on FDC
FDC’s Q1FY21 ahead of our estimates. Revenues declined 10% YoY/ 7.5% QoQ to Rs 3.08bn, reflecting the impact of the Covid-19 pandemic and consequent lockdown across markets. Pandemic impacted anti-infectives and rehydration salts while export business continues to grow. Despite lower top-line, gross margins improved owing to price increases and lower spend aided the company to register highest EBITDA and PAT of Rs 1.04bn and Rs 917mn respectively. EBITDA margins for the quarter improved to 33.6% vs. 22.8% YoY vs. 8.8% QoQ. We expect growth recovery in India beyond 2H and export business to drive earnings with lower spend. We have raised our FY21E/FY22E earnings by 12%/15%, respectively. Maintain Buy with 18xFY22E and TP at Rs 425.
1:00 PM
Voda Idea gains 10% on board nod to raise Rs 25,000 crore via shares, debt
Shares of Vodafone Idea (VIL) rose as much as 10 per cent to Rs 13.21 on the BSE on Monday after the company’s board approved fund raising by up to Rs 25,000 crore by way of share sale and debt. After market hours on Friday, VIL had announced a fund raising of Rs 15,000 crore of equity and debt instruments each with aggregate quantum capped at Rs 25,000 crore. VIL is owned by Vodafone plc and the Aditya Birla group. READ MORE
1:00 PM
BROKERAGE VIEW:: Prabhudas Lilladher on Coal India
Rating: HOLD | CMP: Rs 132 | TP: Rs 150
Coal India (COAL) reported Q1FY21 EBITDA in line with our expectation. In spite of attractive valuations (EV/EBITDA at 2.5x FY22e), stock would continue to remain under pressure due to frequent stake sale by Govt and pressure on profitability in E-auction (contributes>50% of EBITDA) in light of weak global prices and sluggish demand. Release of additional supplies due to upcoming auction of coal mining would further dampen outlook on E-auction segment. Considering all these structural issues, we maintain Hold rating with TP of Rs150.
Coal India (COAL) reported Q1FY21 EBITDA in line with our expectation. In spite of attractive valuations (EV/EBITDA at 2.5x FY22e), stock would continue to remain under pressure due to frequent stake sale by Govt and pressure on profitability in E-auction (contributes>50% of EBITDA) in light of weak global prices and sluggish demand. Release of additional supplies due to upcoming auction of coal mining would further dampen outlook on E-auction segment. Considering all these structural issues, we maintain Hold rating with TP of Rs150.
12:57 PM
BROKERAGE VIEW:: ICICI Securities on Jubilant Life
RATING: BUY | TARGET PRICE: Rs 822
Considering recent rally in stock, we downgrade it to HOLD from Add with revised target of Rs822 based on FY22E, 8x pharma EBITDA and 4x LSI EBITDA (earlier: Rs749). We have raised target EV/EBITDA for pharma business from 7x to 8x considering potential for additional business from COVID-19 related contracts. Key downside risks: Regulatory hurdles and delay in ramp-up in Ruby-Fill.
Key upside risks: Additional business from Covid-19 related contracts.
Considering recent rally in stock, we downgrade it to HOLD from Add with revised target of Rs822 based on FY22E, 8x pharma EBITDA and 4x LSI EBITDA (earlier: Rs749). We have raised target EV/EBITDA for pharma business from 7x to 8x considering potential for additional business from COVID-19 related contracts. Key downside risks: Regulatory hurdles and delay in ramp-up in Ruby-Fill.
Key upside risks: Additional business from Covid-19 related contracts.
12:55 PM
BROKERAGE VIEW:: LKP Securities on IndusInd Bank
Core operating performance of Indusind Bank remains healthy. A higher COVID provision is likely to safeguard the bank from credit disruption from COVID. Thus we recommend a BUY with price target of Rs 705 (based on 1.1x FY22E Adj. BVPS).
Topics : Markets Vodafone Idea Bank of Baroda Bank of India Canara Bank Union Bank of India NMDC Dilip Buildcon MARKET WRAP
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 07 2020 | 7:42 AM IST